Goodwin

Partner

A partner in Goodwin’s Life Sciences group and Intellectual Property practice, Carl Morales applies his scientific and legal training toward acquiring, protecting and managing patent rights for clients in the biotechnology, chemistry, pharmaceutical and medical device industries.

Carl has particular expertise in developing and prosecuting complex patent portfolios for small molecule drug products, including for products involved or expected to be involved in patent litigation. He devises and executes strategies to secure second and third generation patent coverage that extends pharmaceutical product exclusivity (e.g., formulation, dosing regimens and impurity profiles). Carl also routinely conducts due diligence on life science patent portfolios for a variety of transactions, including licensing deals, acquisitions, investments and royalty purchases.

Carl has prepared and prosecuted patent applications in the US Patent and Trademark Office and numerous foreign patent offices. His practice also includes pre-litigation case assessments as well as preparing patentability, validity, infringement and enforcement opinions. He is experienced in post-grant patent proceedings when product-critical patents are at stake, such as reissues, reexaminations and European oppositions. Carl has also prepared numerous patent term adjustment petitions and patent term extension applications and conducted Orange Book listing investigations.

PhD, Synthetic Organic Chemistry, Harvard University / JD, New York University School of Law / MS, Physical Organic Chemistry, Carnegie Mellon University / AM Organic Chemistry, Harvard University / BS, Chemistry, Economics and Business, Carnegie Mellon University